For the third time in  months the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety In an alert issued late last week the FDA took the unusual step of including a link to a page inspection report that was completed July  showing numerous instances in which NuVision failed to investigate batches of various medicines after finding sterility problems The FDA noted in its alert that these medicines had been marketed to the public as sterile